XIAP Antibody (YA5906)
(Synonyms: XIAP; API3; BIRC4; IAP3; E3 ubiquitin-protein ligase XIAP; Baculoviral IAP repeat-containing protein 4; IAP-like protein; ILP; hILP; Inhibitor of apoptosis protein 3; IAP-3; hIAP-3; hIAP3; X-linked inhibitor of apoptosis protein; X-linked I)Based on 1 Customer Validation
XIAP Antibody (YA5906) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to XIAP.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, ICC/IF, IP, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
IP
IP: Immunoprecipitation
|
|---|---|---|---|---|
| Dilution Ratio | 1:2000-1:10000 | 1:200-1:1000 | 1:5000-1:20000 | 1:50-1:200 |
Product Details
XIAP Antibody (YA5906) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to XIAP.
-
Host Rabbit
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 57 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 57 kDa
Protein A
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Verification Images
-
Western blot analysis of extracts from Hela (lane 2, 20ug), C6 (lane3, 20μg) and Jurkat (lane4, 20μg) using XIAP Antibody (HY-P86214). Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/2000) and Loading control antibody (Beta Actin, HY-P80993, 1/10,000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HY-P8001,1/10,000) was used for 1 hour at room temperature.
-
Western blot analysis of extracts from A549 (lane 1(20μg)) and C6 (lane 2(20μg)) using XIAP Antibody (HY-P86214) . Proteins were transferred to a PVDF membrane and blocked with 5% nonfat dry milk in TBST for 1.5 hour at room temperature. The primary antibody (1/2000) and Loading control antibody (β Actin, 1/10000) was used in 5% nonfat dry milk in TBST at 4℃ overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (1/10,000) was used for 1 hour at room temperature.
Background
-
Function
XIAP is a core inhibitor of apoptosis protein that directly restrains executioner caspase-3 and caspase-7 through BIR2-region mechanisms and inhibits initiator caspase-9 through BIR3 binding[1][2][3]. Mechanistically, its RING domain also supports E3 ubiquitin-ligase activity, linking XIAP biology to protein stability, apoptosis regulation, and non-apoptotic signaling contexts[4]. In innate immune signaling, XIAP ubiquitylates RIPK2 and recruits LUBAC after NOD2 stimulation, thereby enabling NF-κB activation and proinflammatory cytokine secretion[5]. In disease models and patient studies, XIAP deficiency associates with Crohn disease-like inflammatory bowel disease and defective NOD2 function in monocytes[6]. Compared with related cIAP1 and cIAP2 isoforms, XIAP has the clearest biochemical role as a direct caspase inhibitor, whereas cIAP1 and cIAP2 bind but do not efficiently inhibit caspases[7]. For experimental applications, selective XIAP antagonism can block NOD2-mediated inflammatory signaling by disrupting the XIAP-RIPK2 interaction, while broader IAP antagonists are used to test apoptosis sensitization mechanisms involving XIAP and cIAP proteins[8][9].- XIAP directly controls caspase-dependent apoptosis and connects apoptosis biology with inflammatory NOD2 signaling[1][5].- XIAP differs from cIAP1/cIAP2 because it directly inhibits caspase activity[7].- XIAP-RIPK2 antagonism provides a practical model for studying NOD2-driven inflammation[8].
-
Subcellular Localization
Cytoplasm; Nucleus
-
Expression
Tissue_specificity:Expressed in colonic crypts (at protein level) (PubMed:30389919) . Ubiquitous, except peripheral blood leukocytes (PubMed:8654366) -
Subunit
Monomer, and homodimer. Part of a complex composed of SEPTIN4 isoform ARTS, XIAP and BCL2, within the complex interacts with SEPTIN4 isoform ARTS and BCL2, SEPTIN4 isoform ARTS acts as a scaffold protein and stabilizes the complex (PubMed:29020630). Interacts (via BIR3 domain) with DIABLO/SMAC; the interaction inhibits apoptotic suppressor activity (PubMed:11140637, PubMed:11257230, PubMed:21695558). Interacts with HTRA2/PRSS25; the interaction inhibits apoptotic suppressor activity (PubMed:11604410). Interacts with TAB1/MAP3K7IP1 and AIFM1. Interaction with DIABLO/SMAC hinders binding of TAB1/MAP3K7IP1 and AIFM1. Interacts with TCF25 and COMMD1. Interacts (via BIR3 domain) with SEPTIN4 isoform ARTS (PubMed:15029247, PubMed:21695558). Interacts (via BIR3 domain) with SEPTIN4 (By similarity). Interacts with RIP1, RIP2, RIP3, RIP4, CCS and USP19. Interacts (via BIR 2 domain and BIR 3 domain) with HAX1 (via C-terminus) and this interaction blocks ubiquitination of XIAP/BIRC4. Interacts with the monomeric form of BIRC5/survivin. Interacts with TLE3 and TCF7L2/TCF4. Interacts (via BIR 3 and RING domains) with PDCL3 (PubMed:19012568)
-
SwissProt ID
-
Synonyms
XIAP; API3; BIRC4; IAP3; E3 ubiquitin-protein ligase XIAP; Baculoviral IAP repeat-containing protein 4; IAP-like protein; ILP; hILP; Inhibitor of apoptosis protein 3; IAP-3; hIAP-3; hIAP3; X-linked inhibitor of apoptosis protein; X-linked I
Documentation
References
[1]. Riedl SJ, et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 2001 Mar 9;104(5):791-800. [Content Brief]
[2]. Chai J, et al. Structural basis of caspase-7 inhibition by XIAP. Cell. 2001 Mar 9;104(5):769-80. [Content Brief]
[3]. Shiozaki EN, et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell. 2003 Feb;11(2):519-27. [Content Brief]
[4]. Galbán S, et al. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010 Jan;17(1):54-60. [Content Brief]
[5]. Damgaard RB, et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell. 2012 Jun 29;46(6):746-58. [Content Brief]
[6]. Aguilar C, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014 Nov;134(5):1131-41.e9. [Content Brief]
[7]. Eckelman BP, et al. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem. 2006 Feb 10;281(6):3254-60. [Content Brief]
[8]. Goncharov T, et al. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling. Mol Cell. 2018 Feb 15;69(4):551-565.e7. [Content Brief]
[9]. Ndubaku C, et al. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists. ACS Chem Biol. 2009 Jul 17;4(7):557-66. [Content Brief]